Medicinal composition containing candesartan cilexetil and hydrochlorothiazide and preparation method thereof

A technology for candesartan medoxomil and hydrochlorothiazide is applied in the field of pharmaceutical compositions containing candesartan medoxomil and hydrochlorothiazide and the field of preparation thereof, which can solve the problems of poor formulation dissolution rate, large numerical value, etc. Production cost, good stability

Inactive Publication Date: 2011-08-03
HAINAN ZHONGJI MEDICAL TECH
View PDF7 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In this patent, polyethylene glycol 6000 is preferred as the low melting point oily compound in the examples, but the dosage is 6.0 parts by weight, which is relatively large, and the dissolution rate of the preparation is not good.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal composition containing candesartan cilexetil and hydrochlorothiazide and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] 1. Prescription

[0054] candesartan cilexetil

8g

Hydrochlorothiazide

6.25g

lactose monohydrate

80g

microcrystalline cellulose

30g

Croscarmellose Sodium

2.6g

polyethylene glycol 6000

2.6g

Magnesium stearate

1.3g

8% high substituted hydroxypropyl cellulose aqueous solution

Appropriate amount

production

1000 pieces

[0055] 2. Preparation process

[0056] 1) Pass candesartan cilexetil and hydrochlorothiazide through an 80-mesh sieve respectively, and set aside;

[0057] 2) Pass lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, polyethylene glycol 6000, magnesium stearate, and high-substituted hydroxypropyl cellulose through a 60-mesh sieve respectively, and set aside;

[0058] 3) Weigh the candesartan cilexetil, hydrochlorothiazide, lactose monohydrate, microcrystalline cellulose, croscarmellose sodium and polyethylene glycol 6000 in th...

Embodiment 2

[0063] 1. Prescription

[0064] candesartan cilexetil

8g

Hydrochlorothiazide

6.25g

lactose monohydrate

70g

microcrystalline cellulose

40g

Croscarmellose Sodium

2.6g

polyethylene glycol 6000

2.6g

Magnesium stearate

1.3g

8% high substituted hydroxypropyl cellulose aqueous solution

Appropriate amount

production

1000 pieces

[0065] 2. Preparation process

[0066] 1) Pass candesartan cilexetil and hydrochlorothiazide through an 80-mesh sieve respectively, and set aside;

[0067] 2) Pass lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, polyethylene glycol 6000, magnesium stearate, and high-substituted hydroxypropyl cellulose through a 60-mesh sieve respectively, and set aside;

[0068] 3) Weigh the candesartan cilexetil, hydrochlorothiazide, lactose monohydrate, microcrystalline cellulose, croscarmellose sodium and polyethylene glycol 6000 in th...

Embodiment 3

[0073] 1. Prescription

[0074] candesartan cilexetil

8g

Hydrochlorothiazide

6.25g

lactose monohydrate

80g

microcrystalline cellulose

30g

Croscarmellose Sodium

5.2g

polyethylene glycol 6000

2.6g

Magnesium stearate

1.3g

8% high substituted hydroxypropyl cellulose aqueous solution

Appropriate amount

production

1000 pieces

[0075] 2. Preparation process

[0076] 1) Pass candesartan cilexetil and hydrochlorothiazide through an 80-mesh sieve respectively, and set aside;

[0077] 2) Pass lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, polyethylene glycol 6000, magnesium stearate, and high-substituted hydroxypropyl cellulose through a 60-mesh sieve respectively, and set aside;

[0078] 3) Weigh the candesartan cilexetil, hydrochlorothiazide, lactose monohydrate, microcrystalline cellulose, croscarmellose sodium and polyethylene glycol 6000 in th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
hardnessaaaaaaaaaa
diameteraaaaaaaaaa
hardnessaaaaaaaaaa
Login to view more

Abstract

The invention relates to a medicinal composition containing candesartan cilexetil and hydrochlorothiazide and a preparation method thereof. The medicinal composition comprises the following components in parts by weight: 4 or 8 parts of candesartan cilexetil, 6.25 parts of hydrochlorothiazide, 60 to 100 parts of lactose monohydrate, 15 to 40 parts of microcrystalline cellulose, 2.6 parts of croscarmellose sodium, 2.6 parts of polyglycol 6000, and 1.3 parts of magnesium stearate. After the medicinal composition is uniformly mixed, an 8 percent high-substitution hydroxypropyl cellulose aqueous solution is used as a binder to granulate by a wet method and to tablet. In the method, by adopting a certain amount of the polyglycol 6000 as a stabilizer, the preparation stability is remarkably improved; and over 90 percent of dissolution rate can be achieved in 45 minutes by adopting less disintegrant and binder; the preparation method has a simple production process without adding extra equipment; the tablets produced according to the method has good stability and high disintegration speed, so that the dissolution of the medicament is remarkably improved, and measurement proves that: the dissolution of the tablets prepared by adopting the method reaches over 90 percent in 45 minutes.

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical preparations, and relates to a pharmaceutical composition containing candesartan cilexetil and hydrochlorothiazide and a preparation method thereof. Background technique [0002] Hypertension is the most common cardiovascular disease and a major public health problem worldwide. The main goal of treating hypertension is to minimize the risk of cardiovascular morbidity and mortality. At present, the prevalence of hypertension in the world is 31.3%, and those who die from hypertension-related diseases account for 6% of the world's death population every year. Hypertension is one of the most important independent risk factors for cardiovascular disease. It often coexists with dyslipidemia, insulin resistance, diabetes, or obesity, causing damage to important target organs such as the heart, brain, and kidneys, and is associated with stroke, coronary heart disease, and kidney disease. are clos...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/4184A61K31/549A61K9/20A61K47/32A61K47/38A61P9/12
Inventor 刘启兵杨贵方肖文礼
Owner HAINAN ZHONGJI MEDICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products